Navigation Links
Daiichi Sankyo, Inc. Establishes Subsidiary in Puerto Rico

New office will provide marketing support to improve awareness and knowledge of Daiichi Sankyo's innovative treatments

PARSIPPANY, N.J., Jan. 7 /PRNewswire/ -- Daiichi Sankyo, Inc., announced today that it has established a subsidiary -- Daiichi Sankyo de Puerto Rico, Inc. Daiichi Sankyo de Puerto Rico, Inc. is based in San Juan, and led by Jose Vazquez, Regional Director -- Puerto Rico, who has more than 20 years of experience in pharmaceutical sales and marketing. Vazquez, who earned his Bachelor of Arts degree in Biology and Juris Doctor from the University of Puerto Rico, has assembled an experienced team of sales representatives and marketing professionals with many years of experience and deep knowledge of the local market in Puerto Rico.

"We are excited about the opening of this new office in Puerto Rico. Our presence here enables us to establish close ties with healthcare partners throughout Puerto Rico and to directly support our customers with educational materials and managed care programs," said Vazquez. "The opening of this office is another indication of the growth of Daiichi Sankyo, which is fueled by our expanding portfolio of marketed products, as well as by our robust pipeline of promising new compounds. The new office in San Juan will ensure that our Puerto Rico customers have direct access to information about these innovative products."

Daiichi Sankyo de Puerto Rico, Inc., as a sales agent for Daiichi Sankyo, Inc. in Puerto Rico, will provide the local medical community and their patients direct access to materials and information about Daiichi Sankyo, Inc.'s products that address medical needs in cardiovascular and diabetes care. Daiichi Sankyo's current portfolio of marketed products is focused on hypertension, cholesterol and type 2 diabetes. The current focus of Daiichi Sankyo's research and development is cardiovascular and metabolic disease, including therapies for dyslipidemia, hypertension, diabetes and acute coronary syndrome. Daiichi Sankyo is also pursuing the discovery of new medicines in the areas of thrombosis, cancer, diabetes, and autoimmune disease/rheumatoid arthritis.

The new Daiichi Sankyo de Puerto Rico, Inc. office is located at The Atrium Office Center, 530 Avenida de la Constitucion, Office Number 258, Puerta de Tierra, San Juan, Puerto Rico 00901-2304. The office's main telephone number is 787-289-8700.

About Daiichi Sankyo

A global pharma innovator, Daiichi Sankyo Co., Ltd., was established in 2005 through the merger of two leading Japanese pharmaceutical companies. This integration created a more robust organization that allows for continuous development of novel drugs that enrich the quality of life for patients around the world. A central focus of Daiichi Sankyo's research and development are thrombotic disorders, malignant neoplasm, diabetes mellitus, and autoimmune disorders. Equally important to the company are hypertension, hyperlipidemia or atherosclerosis and bacterial infections. For more information, visit

Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Daiichi Sankyo Co., Ltd. For more information on Daiichi Sankyo, Inc., please visit

SOURCE Daiichi Sankyo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Daiichi Sankyo, Inc. Awarded Prestigious NCQA Certification for National Under Pressure(TM) Hypertension Management Program
2. Daiichi Sankyo, Inc. Announces Three Studies of Oral Factor Xa Inhibitor DU-176b Accepted for the 50th Annual Meeting of the American Society of Hematology
3. Ranbaxy to Bring in Daiichi Sankyo as Majority Partner; Strategic Combination Creates Innovator and Generic Pharma Powerhouse
4. Daiichi Sankyo, Lilly Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel
5. Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize
6. Cystic Fibrosis Foundation Establishes Landmark Patient Assistance Foundation
7. Body-Jet Water-Assisted Liposuction Establishes New Standard for Liposuction and Fat Harvesting
8. Johnson & Johnson Establishes Wellness & Prevention Platform with Acquisition of HealthMedia, Inc.
9. Halleland Health Consulting Establishes URAC Accreditation Program
10. Jenny Craig Establishes License Agreement for Volumetrics(R)
11. Disabled Veteran Establishes Non-Profit, AVHRT, to House Injured Veterans
Post Your Comments:
(Date:12/1/2015)... , ... December 01, 2015 , ... ... radiographic technicians must mark the film for accurate interpretation by the radiologist. The ... Fortunately, an inventor from Sacramento, Calif., has found a way to alleviate this ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... (BHCOE) today announced that the organization has awarded Education and Developmental Therapies (EDT), ... Distinguished Award. The award celebrates exceptional special needs providers that excel in synthesizing ...
(Date:12/1/2015)... , ... December 01, 2015 , ... Lutronic, a leading ... Clarity, the latest addition to the devices for sale in the United States. ... Alexandrite and long-pulsed 1064 nm Nd:YAG lasers, into a single platform that is easy ...
(Date:12/1/2015)... ... December 01, 2015 , ... XTC Semifinals 2016 ... semi-finalists to head to Las Vegas for CES 2016, the world’s largest Consumer Electronic ... Consumer Technology Association Gary Shapiro, Founding Partner of Pacific Investments Veronica Serra, and venture ...
(Date:12/1/2015)... , ... December 01, 2015 , ... Nurotron Biotechnology Co., ... its largest order to date. , The order will be from the China ... Venus Cochlear Implant System is an effective solution for children and adults suffering from ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015  Athletic apparel ... founder have agreed to pay $1.35 million to ... advertised the company,s copper-infused compression clothing would relieve ... arthritis and other diseases. Tommie ... requires the company and its founder and chairman ...
(Date:12/1/2015)... , Dec. 1, 2015 Assurex Health, ... GeneSight® Psychotropic test giving healthcare providers an expanded range ... for patients suffering from depression, anxiety, bipolar disorder, ... health conditions. i .   ... With the addition of two new drug ...
(Date:12/1/2015)... Calif. , Dec. 1, 2015 ... products and services, announced today that it has been ... services organization. Members served by Novation will have access ... devices, sports bracing products and soft goods dedicated to ... --> The aging U.S. population, rising prevalence ...
Breaking Medicine Technology: